European Commission stops marketing of AstraZeneca vaccine against Covid

From this Tuesday, the Covid-19 vaccine made in the name of vaccine will no longer be marketed in Europe. Vaxgeria and he has evolved AstraZeneca, This is the decision of the European Commission after the pharmaceutical company itself requested its withdrawal from the market on March 5. After evaluating the request, the European body has finally given the green light to the measure.

Last week, pharmaceutical company AstraZeneca admitted for the first time that its coronavirus vaccine could cause this problem. Side effects Rare such as thrombosis. An effect that was already reported in the midst of the pandemic and which caused the said road to be limited during 2021.

You may be interested in: When Spain turned the page on Covid: After Easter, the virus continues to kill people at a rapid pace

AstraZeneca’s Spanish subsidiary has issued an official statement assessing the situation. In a document they say: “We are incredibly proud of the role Vaxzeveria has played in ending the global pandemic. According to independent estimates, in the first year of use alone, more than 6.5 million lives were saved. 3 billion doses worldwide, In it they say: “Our efforts have been recognized by governments around the world and are widely considered a fundamental component in ending the global pandemic.”

The pharmaceutical company that produces the vaccine does not directly link the recall of its vials in Europe to various judicial procedures that have been opened in recent months due to side effects that have occurred in various patients. “Since several updated vaccines have been developed for COVID-19 variants, there is now a plethora of vaccines available. Due to this a Decline in demand for VaxzervariiaWhich is no longer manufactured or supplied,” he says from AstraZeneca.

Four years after hitting the market, AstraZeneca finally confirmed that its vaccine to fight COVID-19, Vaxzervaria, can cause side effects. The company is receiving several class action lawsuits claiming it caused the road it developed at the University of Oxford Serious injuries and deaths of dozens of people,

In a document presented to the Superior Court during the month of February, the pharmaceutical company said that its coronavirus vaccine, “in very rare cases, may cause TTS.”Thrombosis syndrome with thrombocytopenia)” This syndrome causes people to suffer from blood clots and low blood platelet counts.

You may be interested in: What’s behind the rare adverse effects caused by COVID vaccination?

“It is recognized that the AZ vaccine may, in very rare cases, cause TTS. The causal mechanism is unknown. Additionally, TTS can occur in the absence of the AZ vaccine (or any vaccine). “Causation in any individual case will be a matter of expert evidence,” he explained in detail in the document submitted before the Superior Court. It is noteworthy that this is the first time scientists have linked this link between the vaccine and adverse effects. March 2021Fighting the virus began shortly after his vaccination.